Stanford Home
Ovarian Kaleidoscope Database (OKdb)

Home

History

Transgenic Mouse Models

INFORGRAPHICS

Search
Submit
Update
Chroms
Browse
Admin

Hsueh lab

HPMR

Visits
since 01/2001:
176557

Fanconi anemia, complementation group F OKDB#: 4555
 Symbols: FANCF Species: human
 Synonyms: FAF, MGC126856,  Locus: 11p15 in Homo sapiens


For retrieval of Nucleotide and Amino Acid sequences please go to: OMIM Entrez Gene
Mammalian Reproductive Genetics   Endometrium Database Resource   Orthologous Genes   UCSC Genome Browser   GEO Profiles new!   Amazonia (transcriptome data) new!

R-L INTERACTIONS   MGI

DNA Microarrays
SHOW DATA ...
link to BioGPS
General Comment NCBI Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group F. [provided by RefSeq, Jul 2008]
General function
Comment
Cellular localization
Comment
Ovarian function
Comment
Expression regulated by
Comment
Ovarian localization Ovarian tumor
Comment
Follicle stages
Comment
Phenotypes
Mutations 1 mutations

Species: mouse
Mutation name: None
type: null mutation
fertility: infertile - ovarian defect
Comment: Fancf-deficient mice are prone to develop ovarian tumors. Bakker ST et al. Fanconi Anemia (FA) is a rare recessive disorder marked by developmental abnormalities, bone marrow failure, and a high risk for the development of leukemia and solid tumors. The inactivation of FA genes, in particular FANCF, has also been documented in sporadic tumors in non-FA patients. To study whether there is a causal relationship between FA pathway defects and tumor development, we have generated a mouse model with a targeted disruption of the FA core complex gene Fancf. Fancf-deficient mouse embryonic fibroblasts displayed a phenotype typical for FA cells: they showed an aberrant response to DNA crosslinking agents as manifested by G(2) arrest, chromosomal aberrations, reduced survival and an inability to monoubiquitinate FANCD2. Fancf homozygous mice were viable, born following a normal Mendelian distribution and showed no growth retardation or developmental abnormalities. The gonads of Fancf mutant mice functioned abnormally showing compromised follicle development and spermatogenesis as has been observed in other FA mouse models and in FA patients. In a cohort of Fancf-deficient mice, we observed decreased overall survival and increased tumor incidence. Notably, in 7 female mice 6 ovarian tumors developed, 5 granulosa cell tumors and one luteoma. One mouse had developed tumors in both ovaries. High-resolution array comparative genomic hybridization (aCGH) on these tumors suggest that the increased incidence of ovarian tumors correlates with the infertility in Fancf-deficient mice and the genomic instability characteristic for FA pathway deficiency. Copyright 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Genomic Region show genomic region
Phenotypes and GWAS show phenotypes and GWAS
Links
OMIM (Online Mendelian Inheritance in Man: an excellent source of general gene description and genetic information.)
OMIM \ Animal Model
KEGG Pathways
Recent Publications
None
Search for Antibody


created: Sept. 16, 2011, 6:55 p.m. by: hsueh   email:
home page:
last update: Sept. 16, 2011, 6:59 p.m. by: hsueh    email:



Use the back button of your browser to return to the Gene List.

Click here to return to gene search form